Roche Steps Closer To Flu Market Domination With Phase III Baloxavir Results

 
• By Jo Shorthouse
  
Arrow
Roche's antiviral is going in the right direction for December FDA approval
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anti-infective

More from Therapeutic Category